Description

MALEGRA ORAL JELLY 100 MG 5GM

Indications

MALEGRA Oral Jelly 100 mg is primarily indicated for the treatment of erectile dysfunction (ED) in men. ED is characterized by the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. MALEGRA is designed to enhance erectile function when sexual stimulation occurs, thereby improving the quality of sexual experiences for men suffering from this condition.

Mechanism of Action

The active ingredient in MALEGRA Oral Jelly is Sildenafil Citrate, a phosphodiesterase type 5 (PDE5) inhibitor. When a man is sexually stimulated, nitric oxide is released in the corpus cavernosum of the penis, leading to the production of cyclic guanosine monophosphate (cGMP). cGMP causes relaxation of the smooth muscle and dilation of the blood vessels, resulting in increased blood flow to the penis and an erection. Sildenafil works by inhibiting the PDE5 enzyme, which breaks down cGMP, thereby prolonging its action and facilitating an erection when sexual stimulation occurs.

Pharmacological Properties

MALEGRA Oral Jelly is rapidly absorbed after oral administration, with peak plasma concentrations typically achieved within 30 to 120 minutes. The bioavailability of Sildenafil is approximately 40%, and its effects can last for up to 4 to 6 hours. The jelly formulation allows for easier administration and faster absorption compared to traditional tablets, making it a convenient option for patients. It is metabolized primarily in the liver via the cytochrome P450 enzyme system, specifically CYP3A4, and is excreted mainly through the feces and urine.

Contraindications

MALEGRA Oral Jelly should not be used in patients who are hypersensitive to Sildenafil or any of the other components of the formulation. It is contraindicated in individuals who are currently taking nitrates or nitric oxide donors, as the combination can lead to severe hypotension. Additionally, it is not recommended for patients with severe cardiovascular disorders, such as unstable angina, recent myocardial infarction, or severe heart failure, as sexual activity poses a risk to these individuals.

Side Effects

Common side effects associated with MALEGRA Oral Jelly include headache, flushing, dyspepsia, nasal congestion, dizziness, and visual disturbances such as changes in color perception. These side effects are generally mild to moderate and transient. However, in rare cases, more serious side effects can occur, including priapism (a prolonged and painful erection), sudden vision loss, or sudden hearing loss. Patients experiencing any severe or persistent side effects should seek medical attention immediately.

Dosage and Administration

The recommended starting dose of MALEGRA Oral Jelly is 100 mg, taken approximately 30 minutes to 1 hour before sexual activity. The jelly can be consumed directly from the sachet without the need for water. Depending on efficacy and tolerability, the dose may be adjusted to 25 mg or increased to a maximum of 200 mg. It is important not to exceed one dose per day. Patients should be advised to avoid heavy meals prior to taking the medication, as high-fat meals can delay the onset of action.

Interactions

MALEGRA Oral Jelly has the potential to interact with various medications. Concomitant use with nitrates can lead to significant hypotension and is contraindicated. Caution should also be exercised when MALEGRA is used with other antihypertensive agents, as it may enhance the blood pressure-lowering effects. Additionally, medications that affect the CYP3A4 enzyme, such as certain antifungals, antibiotics, and HIV protease inhibitors, may increase Sildenafil levels in the blood, necessitating dose adjustments. Patients should inform their healthcare provider of all medications they are taking to avoid potential interactions.

Precautions

Before initiating treatment with MALEGRA Oral Jelly, a thorough medical history and physical examination should be conducted to rule out any underlying conditions that may contraindicate its use. Patients with pre-existing cardiovascular conditions, liver or kidney impairment, or anatomical deformities of the penis should use MALEGRA with caution. It is also essential to discuss any history of priapism or blood disorders, such as sickle cell anemia, as these may increase the risk of complications. Alcohol consumption should be limited, as it may exacerbate the side effects of MALEGRA and impair the ability to achieve an erection.

Clinical Studies

Clinical studies have demonstrated the efficacy and safety of Sildenafil in treating erectile dysfunction. In a randomized, double-blind, placebo-controlled trial, patients receiving Sildenafil reported significant improvements in erectile function compared to those receiving placebo. The studies indicated that MALEGRA Oral Jelly is effective in a wide range of ED patients, including those with various underlying health conditions. Long-term studies have also shown that the use of Sildenafil does not lead to the development of tolerance, allowing for sustained efficacy over time.

Conclusion

MALEGRA Oral Jelly 100 mg is a valuable treatment option for men experiencing erectile dysfunction. Its unique jelly formulation provides a convenient and effective means of administration, allowing for quicker onset of action. With its proven mechanism of action, MALEGRA can significantly enhance sexual performance and improve the quality of life for men suffering from ED. As with any medication, it is essential for patients to use MALEGRA responsibly and under the guidance of a healthcare professional to ensure safety and efficacy.